Leo Malandain

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Reasons for using antipsychotic polypharmacy (APP) in routine clinical practice, despite a potentially unfavorable risk-benefit ratio, are poorly understood. This research aimed to determine (1) if severe courses of schizophrenia were associated with APP and (2) if a schizophrenia-related acute event would predict a switch to APP in the short term.(More)
  • 1